Many researchers are interested in utilizing state-of-the-art technologies such as microarray-basedtranscriptomic and genomic analyses to attempt to dissect molecular profiles. Within the past decade wehave witnessed significant advancements in research that are directly associated with the output of thegenome sequencing endeavor. The results of these achievements provide hope to investigators researchingcomplex diseases like cancer. Alterations in genes causing these diseases may result in one or severalgenes having aberrant genomic profiles or even hundreds to thousands of genes with perturbed function.This can result in a mishmash of genomic profiles that is difficult to sort through, presenting a challenge toresearchers attempting to elucidate the cause and effect of cancer.To assist BCMCC investigators with these issues, the Genomic Profiling Resource will integrate two existingBaylor College of Medicine (BCM) facilities to provide state-of-the-art access to transcriptional or genomicprofiling using microarray technology. The Resource utilizes spotted glass microarrays and the commerciallyavailable Affymetrix GeneChip platform and offers expert advice in experimental design, data analysis, andbioinformatics, as well as access to computing hardware and software. Services offered by the Resourceinclude sample quality control, expression profiling with microarrays, quantitative (real time) PCR, access toa cDNA clone respository, comparative genomic hybridization on spotted arrays, SNP genotyping utilizingAffymetrix GeneChips, data analysis, training, and workshops. Led by Drs. Lisa White and Ching Lau, thisCore will provide a cost-effective resource for Cancer Center researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA125123-01
Application #
7514637
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$112,819
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhao, Na; Cao, Jin; Xu, Longyong et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest 128:1283-1299
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3
Blue, R Eric; Koushik, Amrita; Engels, Nichlas M et al. (2018) Modulation of alternative splicing of trafficking genes by genome editing reveals functional consequences in muscle biology. Int J Biochem Cell Biol 105:134-143
Dawson, Emily P; Lanza, Denise G; Webster, Nicholas J et al. (2018) Delayed male germ cell sex-specification permits transition into embryonal carcinoma cells with features of primed pluripotency. Development 145:
Freire, Pablo R; Conneely, Orla M (2018) NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBP? and inflammatory signaling. Blood 131:1081-1093
Parikh, Neha; Shuck, Ryan L; Gagea, Mihai et al. (2018) Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice. Aging Cell 17:
Brunetti, Lorenzo; Gundry, Michael C; Kitano, Ayumi et al. (2018) Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. J Vis Exp :
Newton, Jared M; Flores-Arredondo, Jose H; Suki, Sarah et al. (2018) Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response. Sci Rep 8:3474
Bhat, Raksha R; Yadav, Puja; Sahay, Debashish et al. (2018) GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer. Breast Cancer Res Treat 170:279-292
Lyon, Deborah; Lapteva, Natasha; Gee, Adrian P (2018) Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples. Mol Ther 26:6-7

Showing the most recent 10 out of 991 publications